thalidomide has been researched along with methotrexate in 91 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (9.89) | 18.7374 |
| 1990's | 3 (3.30) | 18.2507 |
| 2000's | 21 (23.08) | 29.6817 |
| 2010's | 44 (48.35) | 24.3611 |
| 2020's | 14 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bera, S; Mondal, D | 1 |
| Shepard, TH | 1 |
| Heischkeil, R | 1 |
| Datko, LJ; Kassarich, J; Rosenthale, ME; Schneider, F | 1 |
| Turk, JL; Willoughby, DA | 1 |
| Beckman, DA; Brent, RL | 1 |
| Neubert, D | 1 |
| Jorizzo, JL; Mangelsdorf, HC; White, WL | 1 |
| Johnson, EM | 1 |
| McCune, WJ; Singer, NG | 1 |
| Toussirot, E; Wendling, D | 1 |
| Kaklamani, VG; Kaklamanis, PG | 1 |
| Lichtenstein, GR | 1 |
| Paré, P | 1 |
| Charte González, A; Folch Civit, J; Robert Olalla, J; Rufi Rigau, G; Sanuy Jiménez, B; Vidaller Palacín, A | 1 |
| Baughman, RP; Lynch, JP | 1 |
| DIPAOLO, JA | 1 |
| RODRIGUEZDEAGNESE, LR; YANZON, NA | 1 |
| Kamm, MA | 1 |
| Heath, M; Raugi, GJ | 1 |
| Aikawa, S; Hatta, Y; Horie, T; Ito, T; Kanbe, E; Kitamura, K; Kura, Y; Oka, H; Saiki, M; Sawada, U; Takeuchi, J; Yamazaki, T | 1 |
| Angelucci, E; Caprilli, R; Cocco, A; Viscido, A; Zippi, M | 1 |
| El Maghraoui, A | 1 |
| Bieber, T; Tüting, T; Uerlich, M; Wenzel, J | 1 |
| Colleoni, M; Ghisini, R; Goldhirsch, A; Maisonneuve, P; Nolè, F; Orlando, L; Peruzzotti, G; Rocca, A; Sandri, MT; Sanna, G; Viale, G; Zorzino, L | 1 |
| Byars, T; Cox, CE; Hartung, C; Judson, MA; Silvestri, J | 1 |
| Badgwell, C; Rosen, T | 1 |
| Jorizzo, JL; McCarty, MA; Torti, DC | 1 |
| Colleoni, M; Johansson, HA; Maisonneuve, P; Passerini, R; Peruzzotti, G; Rocca, A; Salvatici, M; Sandri, MT; Zorzino, L | 1 |
| Benevolo, G; Boccadoro, M; Bringhen, S; Callea, V; Capaldi, A; Caravita, T; Cavallo, F; Cavo, M; Ciccone, G; Derudas, D; Dore, F; Falco, P; Falcone, A; Gay, F; Liberati, AM; Montanaro, M; Musto, P; Palumbo, A; Ria, R; Zambello, R | 1 |
| Hou, JK; Mahadevan, U | 1 |
| Byrne, GE; Coleman, F; Escalón, MP; Hosein, PJ; Lossos, IS; Morgensztern, D; Rosenblatt, JD; Walker, GR | 1 |
| Christoulas, D; Dimopoulos, MA; Efstathiou, E; Gavriatopoulou, M; Grapsa, I; Kastritis, E; Matsouka, C; Migkou, M; Mparmparoussi, D; Psimenou, E; Roussou, M; Terpos, E | 1 |
| Bonsmann, G; Kuhn, A; Ruland, V | 1 |
| Fu, WJ; Hou, J; Qu, XY; Wei, W; Xi, H; Zhou, F | 1 |
| Chang, AY; Werth, VP | 1 |
| de Vlam, KL; Hu, C; Joos, R; Papp, K; Rodrigues, JF; Schett, G; Stevens, R; Vessey, AR; Wollenhaupt, J | 1 |
| Adebajo, AO; Gladman, DD; Gomez-Reino, JJ; Hall, S; Hochfeld, M; Hough, D; Hu, C; Kavanaugh, A; Lespessailles, E; Mease, PJ; Schett, G; Stevens, RM; Wollenhaupt, J | 1 |
| Amil Dias, J; Barabino, A; Braegger, CP; Bronsky, J; Buderus, S; De Ridder, L; Dignass, A; Eliakim, A; Escher, JC; Fagerberg, UL; Griffiths, A; Hugot, JP; Kierkus, J; Kolacek, S; Koletzko, S; Kolho, KL; Levine, A; Lionetti, P; Martín-de-Carpi, J; Miele, E; Navas López, VM; Paerregaard, A; Ruemmele, FM; Russell, RK; Serban, DE; Shaoul, R; Turner, D; Van Rheenen, P; Veereman, G; Veres, G; Weiss, B; Wilson, D; Winter, H | 1 |
| Cheng, J; Lamy, T; Loughran, TP; Malysz, J; Ochmann, M; Talamo, G | 1 |
| Foley, P; Kelly, JB; Strober, BE | 1 |
| Gottlieb, AB; Tintle, SJ | 1 |
| Atzeni, F; Sarzi-Puttini, P | 1 |
| Kervarrec, T; Machet, L; Machet, MC; Nadal, M; Petrella, T | 1 |
| Moreau, P; Touzeau, C | 1 |
| Klufas, DM; Strober, BE; Wald, JM | 1 |
| Cronstein, B; Mediero, A; Montesinos, MC; Perez-Aso, M; Schafer, PH; Wilder, T | 1 |
| Corr, M; Kehl, AS; Weisman, MH | 1 |
| Notaro, ER; Sidbury, R | 1 |
| Aldredge, L; Armstrong, AW; Yamauchi, PS | 1 |
| Betts, KA; Friedman, A; Ganguli, A; Griffith, J; Signorovitch, JE; Zhou, ZY | 1 |
| Rahul, N; Sanjay, KS; Singh, S | 1 |
| Garza-Mayers, AC; McClurkin, M; Smith, GP | 1 |
| Armstrong, AW; Betts, KA; Signorovitch, JE; Sundaram, M; Thomason, D | 1 |
| Coates, LC; de Wit, M; Gossec, L; Kavanaugh, A; Mease, PJ; Ramiro, S; Ritchlin, CT; Smolen, JS; van der Heijde, D | 1 |
| Braun, J | 1 |
| Aberer, E; Bata-Csörgő, Z; Caproni, M; Dreher, A; Frances, C; Gläser, R; Klötgen, HW; Kuhn, A; Landmann, A; Marinovic, B; Nyberg, F; Olteanu, R; Ranki, A; Szepietowski, JC; Volc-Platzer, B | 1 |
| Carter, JD; Patel, AA; Raturi, R | 1 |
| Croney, S | 1 |
| Fink, C; Schäkel, K; Schank, TE; Trenkler, N; Uhlmann, L | 1 |
| Nutan, F; Ortega-Loayza, AG | 1 |
| Labuda, SM; Schieffelin, JS; Shaffer, JG; Stryjewska, BM | 1 |
| Lacour, JP | 1 |
| Ng, SC; Shi, HY | 1 |
| Abate, LE; Friedman, AJ; Qureshi, AA; Yosipovitch, G | 1 |
| Ho, RS; Motosko, CC; Mu, EW; Zakhem, GA | 1 |
| Bewley, AP; Calzavara-Pinton, PG; Hansen, JB; Nyeland, ME; Shear, NH; Signorovitch, J | 1 |
| Dressler, C; Eisert, L; Nast, A; Pham, PA; Werner, RN | 1 |
| Dressler, C; Eisert, L; Nast, A; Pham, PA | 1 |
| Billionnet, C; Maura, G; Mezzarobba, M; Sbidian, E; Weill, A | 1 |
| Geng, H; Jia, E; Jiang, Y; Qiu, X; Wei, J; Xiao, M; Xiao, Y; Xie, J; Zhang, J; Zhang, Y; Zhong, L | 1 |
| Bastien, M; Beauchet, A; Becherel, PA; Begon, E; Bilan, P; Boulard, C; Boyé, T; Fougerousse, AC; Gabison, G; Girard, C; Halioua, B; Kemula, M; Kupfer-Bessaguet, I; Le Guyadec, T; Lons-Danic, D; Lorier, E; Maccari, F; Mahé, E; Maillard, H; Mery-Bossard, L; Monfort, JB; Pallure, V; Parier, J; Perrot, JL; Perrussel, M; Pfister, P; Poiraud, C; Quiles-Tsimaratos, N; Steff, M; Sultan, N; Thomas-Beaulieu, D; Vermersch-Langlin, A; Wagner, L; Zeitoun, M | 1 |
| Damiani, G | 1 |
| Armstrong, AW; Connor, C; Cordoro, KM; Davis, DMR; Elewski, BE; Elmets, CA; Gelfand, JM; Gordon, KB; Gottlieb, AB; Hariharan, V; Kaplan, DH; Kavanaugh, A; Kiselica, M; Kivelevitch, D; Korman, NJ; Kroshinsky, D; Lebwohl, M; Leonardi, CL; Lichten, J; Lim, HW; Mehta, NN; Menter, A; Paller, AS; Parra, SL; Pathy, AL; Prater, EF; Rahimi, RS; Rupani, RN; Siegel, M; Stoff, B; Strober, BE; Tapper, EB; Wong, EB; Wu, JJ | 1 |
| Chevreau, J; Foulon, A; Fumery, M; Gondry, J; Yzet, C | 1 |
| Armesto, S; Gómez-Fernández, C; González López, MA; González Vela, C; González-Gay, MA; Illaro, A; López Sundh, AE; Mayorga, J; Naharro Fernández, C; Palmou, N; Sánchez, J | 1 |
| Emeanuru, K; Glynn, M; Guerette, B; Harrold, LR; Liu, M; Mease, PJ; Ogdie, A; Richter, S | 1 |
| Annunziata, MC; Apalla, Z; Carrera, C; Fabbrocini, G; Fattore, D; Giacchero, D; Lallas, A; Lallas, K; Lazaridou, E; Nikolaou, V; Ortiz-Brugués, A; Patri, A; Peris, K; Riganti, J; Rigopoulos, D; Romano, MC; Rossi, E; Sibaud, V; Sollena, P; Stratigos, AJ; Voudouri, D | 1 |
| Dogra, S; Handa, S; Kt, S; Narang, T; Thakur, V | 1 |
| Alderuccio, JP; Alencar, AJ; Iyer, SG; Lossos, IS; Reis, IM; Rosenblatt, JD; Saul, EE | 1 |
| Duvic, M; Joshi, TP | 1 |
| Certan, M; Garcia Garrido, HM; Goorhuis, A; Grobusch, MP; Heijmans, J; Wong, G | 1 |
| Ábalos-Aguilera, MDC; Añón-Oñate, I; Arias de la Rosa, I; Barbarroja, N; Collantes-Estévez, E; Escudero-Contreras, A; Gómez-García, I; Guzmán-Ruiz, R; Ladehesa-Pineda, ML; López-Medina, C; López-Montilla, MD; López-Pedrera, C; Luque-Tévar, M; Malagón, MM; Patiño-Trives, AM; Pérez-Galán, MJ; Pérez-Sánchez, C; Román-Rodríguez, C; Ruiz, D | 1 |
| Bognar, K; Broder, MS; Chang, E; Desai, P; Husni, E; Kaplan, D; Khilfeh, I; Paydar, C; Richter, S; Yan, J | 1 |
| Cheirif-Wolosky, O; Elizalde-Jiménez, IG; Romero, MTG | 1 |
38 review(s) available for thalidomide and methotrexate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Mechanisms of teratogenesis.
Topics: Aminopterin; Androgens; Animals; Antithyroid Agents; Chromosome Aberrations; Coumarins; Diethylstilbestrol; Embryo, Mammalian; Ethanol; Female; Fetus; Humans; Methotrexate; Methylmercury Compounds; Mutagens; Nucleic Acids; Oxazoles; Phenytoin; Polychlorinated Biphenyls; Pregnancy; Progestins; Teratogens; Tetracycline; Thalidomide; Thyroid Hormones | 1984 |
Update on immunosuppressive therapy.
Topics: Adult; Arthritis, Juvenile; Azathioprine; Behcet Syndrome; Child; Cladribine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Hydroxychloroquine; Immunosuppressive Agents; Liver; Lung; Lung Injury; Lupus Erythematosus, Systemic; Methotrexate; Pemphigoid, Benign Mucous Membrane; Retina; Tacrolimus; Thalidomide | 1998 |
Therapeutic advances in ankylosing spondylitis.
Topics: Cyclooxygenase Inhibitors; Diphosphonates; Humans; Methotrexate; Pamidronate; Spondylitis, Ankylosing; Thalidomide; Tumor Necrosis Factor-alpha | 2001 |
Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Etanercept; Female; Gastrointestinal Agents; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Methotrexate; Receptors, Tumor Necrosis Factor; Thalidomide; Treatment Outcome | 2001 |
Management of fistulas in patients with Crohn's disease: antibiotic to antibody.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Colonic Diseases; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Mercaptopurine; Methotrexate; Rectal Fistula; Thalidomide | 2001 |
[Behcet's disease therapy review].
Topics: Behcet Syndrome; Colchicine; Dapsone; Humans; Methotrexate; Prednisone; Thalidomide | 2002 |
Difficult treatment issues in sarcoidosis.
Topics: Antibodies, Monoclonal; Antimalarials; Azathioprine; Cyclophosphamide; Decision Making; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Sarcoidosis; Thalidomide | 2003 |
Review article: chronic active disease and maintaining remission in Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Chronic Disease; Crohn Disease; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Prognosis; Steroids; Thalidomide | 2004 |
Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Azathioprine; Cladribine; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Humans; Immunoglobulin G; Immunologic Factors; Immunotherapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Rituximab; Tacrolimus; Thalidomide | 2004 |
Efficacy of conventional immunosuppressive drugs in IBD.
Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Mycophenolic Acid; Tacrolimus; Thalidomide | 2004 |
[Ankylosing spondylitis].
Topics: Acquired Hyperostosis Syndrome; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Reactive; Behcet Syndrome; Diagnosis, Differential; Diphosphonates; Humans; Immunosuppressive Agents; Lung; Methotrexate; Pamidronate; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine; Thalidomide; Tomography, X-Ray Computed | 2004 |
[Systemic treatment of cutaneous lupus erythematosus].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antimalarials; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Dapsone; Dermatologic Agents; Female; Gold; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Lupus Erythematosus, Cutaneous; Male; Methotrexate; Plasmapheresis; Pregnancy; Retinoids; Thalidomide; Time Factors | 2003 |
Cutaneous sarcoidosis therapy updated.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Allopurinol; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antigen Presentation; Antimalarials; Chlorambucil; Contraindications; Cyclosporine; Cytokines; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Laser Therapy; Leflunomide; Male; Melatonin; Methotrexate; Models, Immunological; Pentoxifylline; Pregnancy; Pregnancy Complications; Sarcoidosis; Skin Diseases; Tetracyclines; Th1 Cells; Thalidomide | 2007 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
Treatment of cutaneous lupus.
Topics: Administration, Topical; Antimalarials; Calcineurin Inhibitors; Dapsone; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Severity of Illness Index; Sunscreening Agents; Thalidomide | 2011 |
Current and future oral systemic therapies for psoriasis.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Cyclosporine; Fumarates; Humans; Hydroxyurea; Immunosuppressive Agents; Isoxazoles; Keratolytic Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Sulfasalazine; Thalidomide; Thioguanine | 2015 |
Psoriatic arthritis for the dermatologist.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthralgia; Arthritis, Psoriatic; Dermatology; Drug Resistance; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Protein Kinase Inhibitors; Thalidomide; Tumor Necrosis Factor-alpha; Ustekinumab | 2015 |
Multiple myeloma: from front-line to relapsed therapies.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Humans; Methotrexate; Multiple Myeloma; Neoplasm Recurrence, Local; Oligopeptides; Randomized Controlled Trials as Topic; Salvage Therapy; Stem Cell Transplantation; Thalidomide; Transplantation, Autologous; Vincristine | 2015 |
Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Autoimmunity; Bone Morphogenetic Proteins; Cytokines; Fibrocartilage; Humans; Interleukin-22; Interleukin-23; Interleukins; Magnetic Resonance Imaging; Methotrexate; Rheumatic Diseases; Rituximab; Spondylarthropathies; Tendinopathy; Thalidomide; Tumor Necrosis Factor-alpha; Versicans | 2016 |
Systemic Agents for Severe Atopic Dermatitis in Children.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Drug Administration Routes; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Severity of Illness Index; Thalidomide | 2015 |
Managing Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care Practitioners.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Insurance, Health, Reimbursement; Keratolytic Agents; Medication Adherence; Methotrexate; Psoriasis; Symptom Flare Up; Thalidomide | 2016 |
An indirect comparison and cost per responder analysis of adalimumab, methotrexate and apremilast in the treatment of methotrexate-naïve patients with psoriatic arthritis.
Topics: Adalimumab; Antirheumatic Agents; Arthritis, Psoriatic; Bayes Theorem; Biological Products; Clinical Trials, Phase III as Topic; Comparative Effectiveness Research; Costs and Cost Analysis; Health Care Costs; Humans; Methotrexate; Models, Economic; Network Meta-Analysis; Randomized Controlled Trials as Topic; Thalidomide; Treatment Outcome | 2016 |
Review of treatment for discoid lupus erythematosus.
Topics: Adrenal Cortex Hormones; Calcineurin Inhibitors; Dapsone; Humans; Hydroxychloroquine; Laser Therapy; Lupus Erythematosus, Discoid; Methotrexate; Phototherapy; Retinoids; Smoking Cessation; Thalidomide | 2016 |
Comparative efficacy and incremental cost per responder of methotrexate versus apremilast for methotrexate-naïve patients with psoriasis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Drug Costs; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Prognosis; Psoriasis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Thalidomide; Treatment Outcome | 2016 |
Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Disease Management; Glucocorticoids; Humans; Methotrexate; Practice Guidelines as Topic; Societies, Medical; Thalidomide; Tumor Necrosis Factor-alpha; Ustekinumab | 2016 |
New targets in psoriatic arthritis.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Cyclophosphamide; Etanercept; Humans; Infliximab; Methotrexate; Molecular Targeted Therapy; Phosphodiesterase 4 Inhibitors; Piperidines; Psoriasis; Pyrimidines; Pyrroles; Sulfasalazine; Thalidomide; Ustekinumab | 2016 |
Two cases demonstrating thalidomide's efficacy in refractory lupus nephritis.
Topics: Adolescent; Adult; Dapsone; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methotrexate; Mycophenolic Acid; Thalidomide; Treatment Outcome | 2017 |
Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antimalarials; Calcineurin Inhibitors; Dapsone; Humans; Immunologic Factors; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Thalidomide | 2017 |
The state of the art on treatment of Crohn's disease.
Topics: Adrenal Cortex Hormones; Asia; Azathioprine; Crohn Disease; Drug Monitoring; Humans; Immunomodulation; Immunosuppressive Agents; Incidence; Infliximab; Methotrexate; Purines; Remission Induction; Thalidomide; Thionucleosides; Treatment Outcome; Tumor Necrosis Factor-alpha | 2018 |
A systematic review of evidence-based treatments for prurigo nodularis.
Topics: Adrenal Cortex Hormones; Anticonvulsants; Antidepressive Agents; Antipruritics; Calcineurin Inhibitors; Calcitriol; Capsaicin; Cyclosporine; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Methotrexate; Photochemotherapy; Prurigo; PUVA Therapy; Thalidomide | 2019 |
Infertility and teratogenicity after paternal exposure to systemic dermatologic medications: A systematic review.
Topics: Acitretin; Adrenal Cortex Hormones; Colchicine; Cyclophosphamide; Dermatologic Agents; Doxycycline; Finasteride; Humans; Infertility, Male; Isotretinoin; Male; Methotrexate; Paternal Exposure; Teratogenesis; Tetracycline; Thalidomide | 2019 |
Time until onset of action when treating psoriatic arthritis: meta-analysis and novel approach of generating confidence intervals.
Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Confidence Intervals; Humans; Infliximab; Methotrexate; Piperidines; Pyrimidines; Pyrroles; Thalidomide; Time Factors; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Ustekinumab | 2019 |
Efficacy and safety of systemic treatments in psoriatic arthritis: a systematic review, meta-analysis and GRADE evaluation.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Dermatologic Agents; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infliximab; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Sulfasalazine; Thalidomide; Ustekinumab | 2019 |
Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: a case report and literature review.
Topics: Antibodies; Asian People; Cyclosporine; Dermatomyositis; Erythema; Female; Humans; Methotrexate; Middle Aged; Prednisolone; Pruritus; Thalidomide; Treatment Outcome; Ubiquitin-Activating Enzymes | 2019 |
[IBD and pregnancy: From conception to birth].
Topics: Cesarean Section; Colitis, Ulcerative; Crohn Disease; Delivery, Obstetric; Female; Fertilization; Fetus; Gestational Age; Humans; Infant, Newborn; Infertility; Inflammatory Bowel Diseases; Male; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Thalidomide | 2020 |
Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options.
Topics: Anti-Infective Agents; Antimalarials; Biological Therapy; Comorbidity; Dermatologic Agents; Diabetes Complications; Diagnosis, Differential; Glucocorticoids; Granuloma Annulare; Humans; Iatrogenic Disease; Infections; Methotrexate; Neoplasms; Pentoxifylline; Phosphodiesterase 4 Inhibitors; Phototherapy; Piperidines; Pyrimidines; Thalidomide | 2022 |
9 trial(s) available for thalidomide and methotrexate
| Article | Year |
|---|---|
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects.
Topics: Administration, Oral; Adult; Aged; Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Thalidomide; Treatment Outcome; Vascular Endothelial Growth Factor A | 2006 |
The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis.
Topics: Adrenal Cortex Hormones; Black or African American; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisone; Prospective Studies; Quality of Life; Sarcoidosis, Pulmonary; Surveys and Questionnaires; Thalidomide; Time Factors; Treatment Outcome; White People | 2006 |
Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cyclophosphamide; Disease Progression; Disease-Free Survival; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Female; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Prospective Studies; Receptor, ErbB-2; Thalidomide | 2007 |
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Follow-Up Studies; Humans; Melphalan; Methotrexate; Middle Aged; Multiple Myeloma; Prednisone; Thalidomide; Treatment Outcome | 2008 |
High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Remission Induction; Rituximab; Thalidomide; Treatment Outcome; Vincristine | 2010 |
Oral apremilast in the treatment of active psoriatic arthritis: results of a multicenter, randomized, double-blind, placebo-controlled study.
Topics: Administration, Oral; Antirheumatic Agents; Arthritis, Psoriatic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Thalidomide; Treatment Outcome | 2012 |
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor.
Topics: Administration, Oral; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Phosphodiesterase 4 Inhibitors; Psoriasis; Thalidomide; Treatment Outcome | 2014 |
Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial.
Topics: Adult; Dermatologic Agents; Female; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Psoriasis; Severity of Illness Index; Thalidomide; Treatment Outcome | 2021 |
R-MACLO-IVAM regimen followed by maintenance therapy induces durable remissions in untreated mantle cell lymphoma - Long term follow up results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Progression-Free Survival; Prospective Studies; Remission Induction; Rituximab; Thalidomide; Vincristine; Young Adult | 2021 |
44 other study(ies) available for thalidomide and methotrexate
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Teratogenicity from drugs--an increasing problem.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Aminopterin; Amniocentesis; Animals; Anti-Bacterial Agents; Azathioprine; Azauridine; Busulfan; Chlorambucil; Colchicine; Contraceptives, Oral; Cyclophosphamide; Diethylstilbestrol; Ethanol; Female; Fetus; Genotype; Humans; Iodine Radioisotopes; Mercaptopurine; Methotrexate; Mice; Nitrogen Mustard Compounds; Phenotype; Pregnancy; Pregnancy, Animal; Prenatal Diagnosis; Radiation Genetics; Rats; Species Specificity; Thalidomide; Tranquilizing Agents | 1974 |
[Antimetabolites of folic acid metabolism with chemotherapeutic activity against rodent malaria (Plasmodium vinckei)].
Topics: Aminopterin; Animals; Cycloheximide; Female; Folic Acid; Folic Acid Antagonists; Hydantoins; Malaria; Male; Methotrexate; Mice; Mice, Inbred Strains; Phenobarbital; Phenytoin; Plasmodium; Primidone; Pyrimethamine; Thalidomide; Triamterene | 1973 |
Teratologists united.
Topics: Abnormalities, Drug-Induced; Animals; Central Nervous System; Congenital Abnormalities; Genetics, Medical; Haplorhini; Humans; Methotrexate; Rats; Societies, Scientific; Thalidomide; Wales; Water Supply | 1971 |
Chemotherapy of experimental allergic encephalomyelitis (EAE).
Topics: Allopurinol; Aminocaproates; Analgesics; Animals; Antineoplastic Agents; Azathioprine; Body Weight; Chloroquine; Colchicine; Cortisone; Cyclophosphamide; Cyproheptadine; Diazoxide; Dimethyl Sulfoxide; Encephalomyelitis, Autoimmune, Experimental; Hydrocortisone; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Methyldopa; Nialamide; Oils; Organ Size; Rats; Strychnine; Talc; Thalidomide; Thioguanine; Thiomalates | 1969 |
An analysis of the multiplicity of the effects of antilymphocyte serum. A comparison with the action of other immunosuppressive agents in the cell-mediated immune response and non-specific inflammation.
Topics: Antibody Formation; Antilymphocyte Serum; Cell Differentiation; Complement Inactivator Proteins; Cyclophosphamide; Hydrolases; Immune Sera; Immunosuppressive Agents; Inflammation; Lymphocytes; Methotrexate; Microscopy, Electron; Phagocytosis; Thalidomide | 1969 |
Teratogenicity: any relationship to carcinogenicity?
Topics: Animals; Carcinogens; Ethanol; Humans; Methotrexate; Mutagens; Teratogens; Testosterone; Thalidomide; Warfarin | 1980 |
Behçet's disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Behcet Syndrome; Colchicine; Dapsone; Dermatologic Agents; Female; Genital Diseases, Female; Genital Diseases, Male; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intralesional; Male; Methotrexate; Middle Aged; Neutrophils; Retrospective Studies; Skin Ulcer; Stomatitis, Aphthous; Thalidomide; United States; Vasculitis, Leukocytoclastic, Cutaneous | 1996 |
A risk assessment of topical tretinoin as a potential human developmental toxin based on animal and comparative human data.
Topics: Abnormalities, Drug-Induced; Administration, Topical; Animals; Female; Humans; Isotretinoin; Keratolytic Agents; Methotrexate; Pregnancy; Risk Assessment; Teratogens; Thalidomide; Tretinoin; Valproic Acid | 1997 |
Treatment of Behçet's disease--an update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chlorambucil; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferons; Levamisole; Male; Methotrexate; Pentoxifylline; Recombinant Proteins; Recurrence; Sulfasalazine; Thalidomide | 2001 |
IN VITRO TEST SYSTEMS FOR CANCER CHEMOTHERAPY. II. CORRELATION OF IN VITRO INHIBITION OF DEHYDROGENASE AND GROWTH WITH IN VIVO INHIBITION OF EHRLICH ASCITES TUMOR.
Topics: Animals; Antineoplastic Agents; Arsenicals; Carbamates; Carcinoma; Carcinoma, Ehrlich Tumor; Colchicine; Dactinomycin; Diethylstilbestrol; Enzyme Inhibitors; Fluorouracil; Hydrocortisone; In Vitro Techniques; Mechlorethamine; Mercaptopurine; Methotrexate; Mice; Oxidoreductases; Research; Thalidomide; Thiotepa | 1963 |
[COMMENTARIES ABOUT 107 CONGENITAL MALFORMATIONS].
Topics: Abnormalities, Drug-Induced; Aminopterin; Chromosome Aberrations; Chromosome Disorders; Congenital Abnormalities; Cortisone; Fetal Death; Hypoglycemic Agents; Infant, Newborn; Methotrexate; Thalidomide; Toxicology | 1963 |
[Multiple myeloma of the IgD-lambda type invading CNS].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Immunoglobulin D; Injections, Spinal; Interferon-alpha; Melphalan; Meningeal Neoplasms; Methotrexate; Middle Aged; Multiple Myeloma; Myeloma Proteins; Neoplasm Invasiveness; Nitrosourea Compounds; Prednisolone; Radiotherapy, Adjuvant; Thalidomide; Vincristine | 2004 |
Oral lichen planus: a case series with emphasis on therapy.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Female; Humans; Immunosuppressive Agents; Lichen Planus, Oral; Male; Methotrexate; Middle Aged; Retinoids; Thalidomide | 2007 |
A 24-year-old pregnant woman with inflammatory bowel disease.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Breast Feeding; Crohn Disease; Female; Fetus; Humans; Infant, Newborn; Infliximab; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Remission Induction; Risk Assessment; Thalidomide; Young Adult | 2009 |
Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Creatinine; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Kidney; Lenalidomide; Male; Methotrexate; Middle Aged; Multiple Myeloma; Renal Insufficiency; Thalidomide | 2010 |
Clinical features of multiple myeloma invasion of the central nervous system in Chinese patients.
Topics: Adult; Aged; Brain; Central Nervous System; Dexamethasone; Female; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Multiple Myeloma; Thalidomide | 2010 |
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.
Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Algorithms; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Crohn Disease; Enteral Nutrition; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Remission Induction; Thalidomide; Tumor Necrosis Factor-alpha | 2014 |
Report of 6 cases of large granular lymphocytic leukemia and plasma cell dyscrasia.
Topics: Aged; Aged, 80 and over; Anemia; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Causality; Cladribine; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Female; Humans; Lenalidomide; Leukemia, Large Granular Lymphocytic; Male; Melphalan; Methotrexate; Middle Aged; Multiple Myeloma; Neutropenia; Paraproteinemias; Peripheral Blood Stem Cell Transplantation; Prednisone; Protease Inhibitors; Pyrazines; Registries; Retrospective Studies; Thalidomide | 2014 |
New biological treatments for psoriatic arthritis.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Psoriatic; Clinical Trials as Topic; Humans; Immunologic Factors; Interleukin-17; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Rituximab; Thalidomide; Tumor Necrosis Factor Inhibitors; Ustekinumab | 2014 |
Cutaneous Rosai-Dorfman Disease Located on the Breast: Rapid Effectiveness of Methotrexate After Failure of Topical Corticosteroids, Acitretin and Thalidomide.
Topics: Acitretin; Administration, Cutaneous; Aged; Anti-Inflammatory Agents; Breast Diseases; Clobetasol; Dermatologic Agents; Female; Histiocytosis, Sinus; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Retreatment; Skin Diseases; Thalidomide; Treatment Failure | 2015 |
The Use of Methotrexate, Alone or in Combination With Other Therapies, for the Treatment of Palmoplantar Psoriasis.
Topics: Adalimumab; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Female; Foot Dermatoses; Hand Dermatoses; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Psoriasis; Severity of Illness Index; Thalidomide; Ustekinumab; Young Adult | 2015 |
Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors.
Topics: Adenosine; Animals; Antirheumatic Agents; Blotting, Western; Cell Line; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytokines; Gene Expression; Guanine Nucleotide Exchange Factors; Inflammation Mediators; Macrophages; Male; Methotrexate; Mice; Phenethylamines; Phosphodiesterase 4 Inhibitors; Receptor, Adenosine A2A; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Thalidomide; Tumor Necrosis Factor-alpha | 2015 |
Effectiveness of Methotrexate in prednisolone and thalidomide resistant cases of Type 2 lepra reaction: report on three cases.
Topics: Adult; Drug Resistance, Bacterial; Humans; Leprosy; Male; Methotrexate; Mycobacterium lepraemurium; Prednisolone; Thalidomide; Treatment Outcome | 2015 |
S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
Topics: Adrenal Cortex Hormones; Antimalarials; Biological Products; Calcineurin Inhibitors; Consensus; Dapsone; Humans; Immunosuppressive Agents; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Practice Guidelines as Topic; Retinoids; Thalidomide | 2017 |
Management of patients with psoriasis.
Topics: Acitretin; Administration, Cutaneous; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Cyclosporine; Dermatologic Agents; Disease Management; Emollients; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Phototherapy; Psoriasis; Thalidomide | 2017 |
Quality of life, treatment satisfaction and efficacy of non-biological systemic therapies in patients with plaque psoriasis: study protocol for a prospective observational study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Fumarates; Humans; Methotrexate; Patient Compliance; Patient Satisfaction; Personal Satisfaction; Pilot Projects; Prospective Studies; Psoriasis; Quality of Life; Thalidomide | 2017 |
Hansen's Disease and Rheumatoid Arthritis Crossover of Clinical Symptoms: A Case Series of 18 Patients in the United States.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Clofazimine; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Methotrexate; Mycobacterium leprae; Retrospective Studies; Rifampin; Skin; Steroids; Thalidomide; United States | 2017 |
[Current and upcoming treatments of adult atopic dermatitis].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Glucocorticoids; Humans; Methotrexate; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Thalidomide; Ustekinumab | 2017 |
Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching-adjusted indirect comparison.
Topics: Acitretin; Administration, Cutaneous; Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Esters; Female; Fumarates; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Thalidomide; Treatment Outcome | 2019 |
Persistence of apremilast in moderate-to-severe psoriasis: a real-world analysis of 14 147 apremilast- and methotrexate-naive patients in the French National Health Insurance database.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Male; Methotrexate; Middle Aged; National Health Programs; Psoriasis; Thalidomide | 2020 |
Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real-world clinical setting.
Topics: Adult; Aged; Clinical Decision-Making; Cross-Sectional Studies; Dermatologic Agents; Female; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Thalidomide | 2019 |
Apremilast does not appear to outlast methotrexate.
Topics: Humans; Methotrexate; National Health Programs; Psoriasis; Thalidomide | 2020 |
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies.
Topics: Acitretin; Cyclosporine; Drug Monitoring; Humans; Methotrexate; Piperidines; Psoriasis; Pyrimidines; Thalidomide | 2020 |
Treating multidrug-resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID-19 pandemic.
Topics: Adult; Antibodies, Monoclonal, Humanized; COVID-19; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Methotrexate; Prednisone; Psoriasis; SARS-CoV-2; Thalidomide | 2020 |
Descriptive Comparisons of the Effect of Apremilast and Methotrexate Monotherapy in Oligoarticular Psoriatic Arthritis: The Corrona Psoriatic Arthritis/Spondyloarthritis Registry Results.
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Drug Therapy, Combination; Humans; Methotrexate; Registries; Spondylarthritis; Thalidomide; Treatment Outcome | 2021 |
Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group.
Topics: Acitretin; Aged; Biological Products; Dermatologic Agents; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; Glucocorticoids; Humans; Immune Checkpoint Inhibitors; Male; Methotrexate; Middle Aged; Neoplasms; Psoriasis; Retrospective Studies; Severity of Illness Index; Thalidomide; Treatment Outcome | 2021 |
Incidence and Predictors of Community-Acquired Pneumonia in Patients With Hematological Cancers Between 2016 and 2019.
Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Cohort Studies; Community-Acquired Infections; Disease Progression; Female; Hematologic Neoplasms; Hospitalization; Humans; Incidence; Lenalidomide; Male; Methotrexate; Pneumonia; Pneumonia, Pneumococcal; Rituximab; Thalidomide | 2022 |
The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast.
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Cardiovascular Diseases; Cross-Sectional Studies; Humans; Leukocytes, Mononuclear; Methotrexate; Thalidomide | 2022 |
Biologic initiation rates in systemic-naive psoriasis patients after first-line apremilast versus methotrexate use.
Topics: Biological Products; Humans; Methotrexate; Psoriasis; Retrospective Studies; Thalidomide | 2022 |
Systemic treatment for severe atopic dermatitis in children: a case series.
Topics: Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Mycophenolic Acid; Prednisone; Thalidomide | 2022 |